Professor Smollen teaches Introduction to Compliance and serves as the Director of the Center for Compliance and Ethics. The Center’s mission is to improve the understanding and practice of compliance across disciplines and industries through innovative courses and educational programming, public-private sector dialogue, and academic research and thought leadership. As the Center’s Director, Professor Smollen leads Temple Law’s efforts to develop innovative courses to teach students interested in careers in compliance. He also serves as the co-editor of the Law School’s Compliance & Risk Management e-journal.
Prior to joining Temple Law, Professor Smollen was Executive Vice President and Chief Compliance Officer for Endo International. At Endo, he oversaw the resolution of civil and criminal investigations of historic pharmaceutical marketing practices and negotiated and implemented Endo’s Corporate Integrity Agreement with OIG and Deferred Prosecution Agreement with the U.S. Department of Justice. He previously served as Vice President and Chief Compliance Officer for Siemens Healthcare U.S and in a number of leadership positions at Wyeth Pharmaceuticals, including Chief Privacy Officer and Senior Counsel on regulatory issues.
Prior to joining the private sector, Professor Smollen was an advisor to FTC Commissioner Thomas B. Leary and an attorney in the FTC’s Bureau of Consumer Protection. He began his legal career at Squire, Sanders, and Dempsey in Washington, D.C and served as a judicial clerk for U.S. District Judge James P. Jones. He received his J.D. from the University of Virginia School of Law, where he served on the Articles Review Board of the Virginia Journal of International Law. He is a cum laude graduate of Georgetown University with a B.A. in history and government and received his M.A. from Columbia University’s School of International and Public Affairs with a focus on international policy economy and human rights.
Professor Smollen is a frequent speaker and lecturer on compliance, healthcare, global anti-corruption and data privacy issues. He served on the Board of the International Pharmaceutical Privacy Consortium from 2003-2006.